Tue, April 9, 2024
Mon, April 8, 2024
Fri, April 5, 2024
Thu, April 4, 2024
Wed, April 3, 2024

Vamil Divan Reiterated (VERA) at Strong Buy and Held Target at $56 on, Apr 5th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-56-on-apr-5th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Guggenheim, Reiterated "Vera Therapeutics, Inc." (VERA) at Strong Buy and Held Target at $56 on, Apr 5th, 2024.

Vamil has made no other calls on VERA in the last 4 months.



There are 5 other peers that have a rating on VERA. Out of the 5 peers that are also analyzing VERA, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $34 on, Thursday, March 21st, 2024


These are the ratings of the 4 analyists that currently disagree with Vamil


  • Steven Seedhouse of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $37 on, Friday, January 26th, 2024
  • Justin Kim of "Oppenheimer" Initiated at Buy and Held Target at $26 on, Thursday, January 25th, 2024
  • Pete Stavropoulos of "Cantor Fitzgerald" Initiated at Buy on, Monday, January 8th, 2024
  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $25 on, Wednesday, December 27th, 2023

Publication Contributing Sources